Seymour and Diwan raised tens of millions from investors based on their claims of having three FULLY IND-APPROVED drugs before end of 2009.
Eleven years and $63M later, and NNVC hasn't even picked a lead to push through IND-approval. Yet Seymour and Diwan have compensated themselves with millions of dollars.
It's the management's history of miserably failing to achieve a single one of their milestones, and enrichment of the founders at the expense of the shareholders, that is at issue: